KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

News: KZA Kazia Therapeutics Entered Licensing Agreement With Simcere Pharmaceutical Group Ltd

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    29/03/21
    19:20
    Post #: 52122950

    March 29 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • ENTERED INTO LICENSING AGREEMENT WITH SIMCERE PHARMACEUTICAL GROUP LTD
    • AGREEMENT TO DEVELOP AND COMMERCIALISE CO'S NEW DRUG, PAXALISIB, IN GREATER CHINA
    • UNDER TERMS OF AGREEMENT, KAZIA WILL RECEIVE AN UPFRONT PAYMENT OF US$11 MILLION
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS PYC Therapeutics moves into final stage of child blindness study
right-arrow Created with Sketch.
NEWS RBA holds rates as ALP election campaigning kicks off – expect more political focus
right-arrow Created with Sketch.
NEWS Westpac records 3% fall in net profit for FY24
right-arrow Created with Sketch.
NEWS Check out the latest ASX news here!
right-arrow Created with Sketch.
NEWS 29Metals greenlit to release more water from flooded Capricorn mine this wet season
right-arrow Created with Sketch.
RMX Red Mountain Mining (ASX:RMX) announces Bonanza Grade Gold Results at Flicka Lake
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.